
Study Period | 2019 - 2030 |
Market Size (2025) | USD 1.01 Billion |
Market Size (2030) | USD 1.33 Billion |
CAGR (2025 - 2030) | 5.70 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Larvicides Market Analysis
The Larvicides Market size is estimated at USD 1.01 billion in 2025, and is expected to reach USD 1.33 billion by 2030, at a CAGR of 5.70% during the forecast period (2025-2030).
The global larvicides market is expanding due to the worldwide prevalence of mosquito and fly-borne diseases, including the Zika virus, dengue, and malaria. According to the World Health Organization in 2022, 29 countries accounted for approximately 95% of malaria cases. The total number of malaria cases worldwide reached 249 million in 2022, showing an increase of 5 million cases from 2021. This rising disease burden is a significant factor driving the larvicides market growth.
Government and organizational initiatives to control mosquito-borne diseases are contributing to market expansion. In the United States, the Environmental Protection Agency (EPA) and the Centers for Disease Control and Prevention (CDC) collaborate with federal, state, and local agencies to protect the public from diseases such as the West Nile virus. This coordinated governmental response supports market development.
Public health concerns have prompted companies to develop advanced mosquito control solutions. In 2021, Valent BioSciences introduced MetaLarv XRP, a formulation designed to control mosquito larvae in catch basins and storm drains. However, the market faces challenges from raw material price fluctuations and high costs associated with larval control methods. Additionally, health risks linked to larvicide products present obstacles to market growth.
Larvicides Market Trends
Mosquito-borne Diseases Drive the Larvicides Market
The larvicides industry is experiencing growth due to the increasing prevalence of mosquito-borne illnesses such as the Zika virus, dengue fever, and malaria. According to the World Health Organization (WHO), mosquito-transmitted diseases like Dengue have seen significant spread. In 2023, global dengue cases reached 5 million, with more than 5,000 dengue-related deaths reported across 80 countries. The Region of the Americas accounted for 80% of these cases, totaling 4.1 million infections. In the United States, 34 states have reported West Nile virus (WNV) infections in people, birds, or mosquitoes to the CDC, with several communities experiencing higher mosquito activity compared to previous years.
The impact of mosquito-borne diseases has been particularly severe in South America. In 2023, the Region of the Americas recorded 2,049 deaths across 42 countries and territories, with Brazil reporting the highest number of suspected cases. Larvicides play a crucial role in managing deadly diseases such as malaria, chikungunya, and dengue. The European region has become more vulnerable to mosquito populations following outbreaks of the Zika virus. Malaria affects multiple regions including Sub-Saharan Africa, the Middle East, Latin America, Asia, and parts of Europe. The increasing cases of dengue and malaria present significant market opportunities for larvicides in these affected regions. The widespread prevalence of mosquito-borne diseases and their continued growth drive the demand for larvicide products, contributing to market expansion during the forecast period.

North America Dominates the Market
North America represents the largest consumer market for larvicides, driven by the significant presence of multinational companies in the region. The United States and Canadian markets show substantial demand due to the increasing prevalence of vector-borne diseases and the implementation of comprehensive surveillance and vector control programs. In 2023, the primary mosquito-borne diseases in the United States included West Nile virus and several types of encephalitis. The region has also witnessed the emergence of Zika virus, dengue fever, and chikungunya in recent years. According to the U.S. Centers for Disease Control and Prevention, West Nile Virus remains the predominant mosquito-borne disease in the United States, with outbreaks occurring annually during the mosquito season from summer through fall.
In Canada, mosquito-borne diseases have increased by 10% over the past 20 years, primarily attributed to climate change. This increase stems from the direct relationship between mosquito life cycles, reproduction, and feeding patterns with temperature, precipitation, and land use patterns. The ongoing climate changes are anticipated to expand mosquito populations in these countries, subsequently increasing the demand for larvicide products. The U.S. Environmental Protection Agency reports that as of 2024, more than 200 mosquito species inhabit the continental United States and U.S. territories.
North American countries have implemented various mosquito control initiatives that incorporate larvicide usage. For example, Edmonton, Canada's 2024 Mosquito Control Activities includes The Ground Control Program, which focuses on proactive mosquito population management to maintain safe and pleasant outdoor spaces. This program specifically targets mosquito larvae in roadside ditches using two bacterial protein-based products that effectively eliminate mosquito larvae. The combination of persistent vector-borne diseases and expanding mosquito control programs is expected to drive the North American larvicides market growth during the forecast period.

Larvicides Industry Overview
The larvicides market has a fragmented structure. Companies including Syngenta Group, BASF, Sumitomo Chemical, Certis USA L.L.C., and Summit Chemical employ various growth strategies such as joint ventures, product launches, partnerships, agreements, expansions, and acquisitions to strengthen their market presence.
Larvicides Market Leaders
-
BASF
-
Sumitomo Chemical
-
Summit Chemical
-
Certis USA L.L.C.
-
Syngenta Group
- *Disclaimer: Major Players sorted in no particular order
Larvicides Market News
- May 2024: BASF introduced the insecticide Efficon in India to control sucking pests. The product targets multiple growth stages of pests, including aphids, jassids, and whiteflies during their larval development.
- May 2023: Valent Biosciences received approval from Canada's Pest Management Regulatory Agency (PMRA) for the drone application of its larvicides (VectoBac 200G, VectoBac 1200L, and VectoLex CG). This approval enables precise application rates and simplifies larvicide adoption in Canada.
Larvicides Industry Segmentation
Larvicides are insecticides that target insects in their larval stage, primarily used for mosquito control. The larvicides market is segmented by control method (biocontrol agents, chemical agents, insect growth regulators), product type (synthetic larvicides, natural larvicides, biological larvicides), application (agricultural and non-agricultural), and geography (North America, Europe, Asia-Pacific, South America, and Africa). The report provides market size and forecasts in USD million for all segments.
Application | Agriculture | ||
Non-agriculture | |||
Control Method | Bio Control Agent | ||
Chemical Agent | |||
Insect Growth Regulator | |||
Product Type | Synthetic Larvicides | ||
Natural Larvicides | |||
Biological Larvicides | |||
Target Insect | Mosquitoes | ||
Flies | |||
Other Target Insects | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Rest of North America | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Russia | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | India | ||
China | |||
Japan | |||
Rest of the Asia-Pacific | |||
South America | Brazil | ||
Argentina | |||
Rest of South America | |||
Africa | South Africa | ||
Rest of Africa |
Larvicides Market Research FAQs
How big is the Larvicides Market?
The Larvicides Market size is expected to reach USD 1.01 billion in 2025 and grow at a CAGR of 5.70% to reach USD 1.33 billion by 2030.
What is the current Larvicides Market size?
In 2025, the Larvicides Market size is expected to reach USD 1.01 billion.
Who are the key players in Larvicides Market?
BASF, Sumitomo Chemical, Summit Chemical, Certis USA L.L.C. and Syngenta Group are the major companies operating in the Larvicides Market.
Which is the fastest growing region in Larvicides Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Larvicides Market?
In 2025, the North America accounts for the largest market share in Larvicides Market.
What years does this Larvicides Market cover, and what was the market size in 2024?
In 2024, the Larvicides Market size was estimated at USD 0.95 billion. The report covers the Larvicides Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Larvicides Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Larvicides Industry Report
Statistics for the 2025 Larvicides market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Larvicides analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.